These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11118011)

  • 1. Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity.
    Dea MK; Van Citters GW; Ader M; Mittelman SD; Sunehag AL; Bergman RN
    Diabetes; 2000 Dec; 49(12):2087-93. PubMed ID: 11118011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
    Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
    Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
    Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
    Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.
    Willi SM; Kennedy A; Wallace P; Ganaway E; Rogers NL; Garvey WT
    Diabetes; 2002 Oct; 51(10):2895-902. PubMed ID: 12351424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of troglitazone on dexamethasone-induced insulin resistance in rats.
    Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K
    Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of troglitazone on leptin production. Studies in vitro and in human subjects.
    Nolan JJ; Olefsky JM; Nyce MR; Considine RV; Caro JF
    Diabetes; 1996 Sep; 45(9):1276-8. PubMed ID: 8772734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troglitazone improves insulin-stimulated glucose utilization associated with an increased muscle glycogen content in obese Zucker rats.
    Oshida Y; Kako M; Nakai N; Shimomura Y; Li L; Sato J; Ohsawa I; Sato Y
    Endocr J; 1999 Oct; 46(5):723-30. PubMed ID: 10670760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.
    Lee MK; Miles PD; Khoursheed M; Gao KM; Moossa AR; Olefsky JM
    Diabetes; 1994 Dec; 43(12):1435-9. PubMed ID: 7958495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
    Oakes ND; Thalén PG; Jacinto SM; Ljung B
    Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone (CS-045) normalizes hypertriglyceridemia and restores the altered patterns of glucose-stimulated insulin secretion in dyslipidemic rats.
    Chicco A; Basabe JC; Karabatas L; Ferraris N; Fortino A; Lombardo YB
    Metabolism; 2000 Oct; 49(10):1346-51. PubMed ID: 11079827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of troglitazone on in vivo insulin action in normal rats.
    Lee MK; Olefsky JM
    Metabolism; 1995 Sep; 44(9):1166-9. PubMed ID: 7666790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
    Frias JP; Yu JG; Kruszynska YT; Olefsky JM
    Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of troglitazone on hepatic and peripheral insulin resistance induced by growth hormone excess in rats.
    Sugimoto M; Takeda N; Nakashima K; Okumura S; Takami K; Yoshino K; Hattori J; Ishimori M; Takami R; Sasaki A; Yasuda K
    Metabolism; 1998 Jul; 47(7):783-7. PubMed ID: 9667221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats.
    Hevener AL; Reichart D; Janez A; Olefsky J
    Diabetes; 2001 Oct; 50(10):2316-22. PubMed ID: 11574414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of troglitazone and D-chiroinositol on glucosamine-induced insulin resistance in vivo in rats.
    Yoshino K; Takeda N; Sugimoto M; Nakashima K; Okumura S; Hattori J; Sasaki A; Kawachi S; Takami K; Takami R; Yasuda K
    Metabolism; 1999 Nov; 48(11):1418-23. PubMed ID: 10582551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic effects of troglitazone on fat-induced insulin resistance in the rat.
    Khoursheed M; Miles PD; Gao KM; Lee MK; Moossa AR; Olefsky JM
    Metabolism; 1995 Nov; 44(11):1489-94. PubMed ID: 7476339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of glucose and insulin in thiazolidinedione-induced alterations in hepatic gluconeogenesis.
    Raman P; Judd RL
    Eur J Pharmacol; 2000 Dec; 409(1):19-29. PubMed ID: 11099696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of troglitazone in young first-degree relatives of patients with type 2 diabetes.
    Levin K; Hother-Nielsen O; Henriksen JE; Beck-Nielsen H
    Diabetes Care; 2004 Jan; 27(1):148-54. PubMed ID: 14693981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.
    Oakes ND; Kennedy CJ; Jenkins AB; Laybutt DR; Chisholm DJ; Kraegen EW
    Diabetes; 1994 Oct; 43(10):1203-10. PubMed ID: 7926289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.